CTLA4 overexpression
|
Soft Tissue Sarcoma
|
CTLA4 overexpression
|
Soft Tissue Sarcoma
|
trabectedin Sensitive: C3 – Early Trials
|
trabectedin Sensitive: C3 – Early Trials
|
CTLA4 overexpression
|
Mantle Cell Lymphoma
|
CTLA4 overexpression
|
Mantle Cell Lymphoma
|
rituximab + ibrutinib Sensitive: C3 – Early Trials
|
rituximab + ibrutinib Sensitive: C3 – Early Trials
|
CTLA4 overexpression
|
Triple Negative Breast Cancer
|
CTLA4 overexpression
|
Triple Negative Breast Cancer
|
Immunotherapy Sensitive: C3 – Early Trials
|
Immunotherapy Sensitive: C3 – Early Trials
|